Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Arterial Hypertension
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 22, No 2 (2018)
Guidelines / Expert consensus
Published online: 2018-06-29
View PDF Download PDF file
Get Citation

Guidelines of the Pediatric Section of the Polish Society of Hypertension on diagnosis and treatment of arterial hypertension in children and adolescents

Mieczysław Litwin1, Anna Niemirska1, Łukasz Obrycki1, Małgorzata Myśliwiec2, Agnieszka Szadkowska3, Mieczysław Szalecki45, Marta Buraczewska2, Grażyna Brzezińska-Rajszys6, Sylwester Prokurat1, Andrzej Tykarski7
DOI: 10.5603/AH.2018.0007
·
Arterial Hypertension 2018;22(2):45-73.
Affiliations
  1. Department of Nephrology, Kidney Transplantation and Hypertension, Children’s Memorial Health Institute, Warsaw
  2. Department of Paediatrics, Diabetology and Endocrinology, Medical University of Gdansk
  3. Department of Paediatrics, Oncology, Haematology and Diabetology, Medical University of Lodz
  4. Department of Endocrinology and Diabetology, Children’s Memorial Health Institute, Warsaw
  5. Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce
  6. Department of Cardiology, Children’s Memorial Health Institute, Warsaw
  7. Chair and Department of Hypertensiology, Angiology and Internal Diseases, Medical University of Poznan

open access

Vol 22, No 2 (2018)
Position paper
Published online: 2018-06-29

Abstract

Presented recommendations are an extended and actualized version of paediatric recommendations of Polish Society of Hypertension published in 2015. Since then, new studies have appeared on this subject, introducing a new classification of hypertension, newly described principles of management in risk groups and methods of assessing hypertensive target organ damage. The presented updated recommendations included changes introduced in the 2016 European Society of Hypertension recommendation and Recommendations of Children’s Memorial Health Institute in Warsaw. Recently published guidelines of American Academy of Paediatrics have been discussed. In the presented issue of guidelines, epidemiological information on the occurrence and incidence of hypertension in developmental age was added and classification of blood pressure values was updated. Subchapters on diagnosis and organ damage assessment, principles of diagnosis and treatment of hypertension in children with diabetes, chronic kidney disease and a subsection discussing diagnostic and therapeutic difficulties with setting blood pressure targets were revised. In addition, the principles of early diagnosis of arterial hypertension in post-hospital care in children born before 33 weeks of gestation published in 2018 as recommendations of the Polish Neonatal Society have been also taken into account.

Abstract

Presented recommendations are an extended and actualized version of paediatric recommendations of Polish Society of Hypertension published in 2015. Since then, new studies have appeared on this subject, introducing a new classification of hypertension, newly described principles of management in risk groups and methods of assessing hypertensive target organ damage. The presented updated recommendations included changes introduced in the 2016 European Society of Hypertension recommendation and Recommendations of Children’s Memorial Health Institute in Warsaw. Recently published guidelines of American Academy of Paediatrics have been discussed. In the presented issue of guidelines, epidemiological information on the occurrence and incidence of hypertension in developmental age was added and classification of blood pressure values was updated. Subchapters on diagnosis and organ damage assessment, principles of diagnosis and treatment of hypertension in children with diabetes, chronic kidney disease and a subsection discussing diagnostic and therapeutic difficulties with setting blood pressure targets were revised. In addition, the principles of early diagnosis of arterial hypertension in post-hospital care in children born before 33 weeks of gestation published in 2018 as recommendations of the Polish Neonatal Society have been also taken into account.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

arterial hypertension, children, adolescents, newborns, recommendations

About this article
Title

Guidelines of the Pediatric Section of the Polish Society of Hypertension on diagnosis and treatment of arterial hypertension in children and adolescents

Journal

Arterial Hypertension

Issue

Vol 22, No 2 (2018)

Article type

Guidelines / Expert consensus

Pages

45-73

Published online

2018-06-29

Page views

2618

Article views/downloads

2025

DOI

10.5603/AH.2018.0007

Bibliographic record

Arterial Hypertension 2018;22(2):45-73.

Keywords

arterial hypertension
children
adolescents
newborns
recommendations

Authors

Mieczysław Litwin
Anna Niemirska
Łukasz Obrycki
Małgorzata Myśliwiec
Agnieszka Szadkowska
Mieczysław Szalecki
Marta Buraczewska
Grażyna Brzezińska-Rajszys
Sylwester Prokurat
Andrzej Tykarski

References (139)
  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390(10113): 2627–2642.
    CrossRefPubMed
  2. Vuguin PM. Animal models for small for gestational age and fetal programming of adult disease. Horm Res. 2007; 68(3): 113–123.
    CrossRefPubMed
  3. Argente J, Mehls O, Barrios V. Growth and body composition in very young SGA children. Pediatr Nephrol. 2010; 25(4): 679–685.
    CrossRefPubMed
  4. Tykarski A, Narkiewicz K, Gaciong Z, et al. 2015 Guidelines for the Management of Hypertension Part 1–7. Recommendations of the Polish Society of Hypertension. Arterial Hypertens. 2015; 19(2): 53–83.
    CrossRef
  5. Kit BK, Kuklina E, Carroll MD, et al. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report): 555–576.
    PubMed
  6. Baumgartner H, Bonhoeffer P, De Groot NM, et al. Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010; 31(23): 2915–2957.
    CrossRefPubMed
  7. Urbina E, Alpert B, Flynn J, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008; 52(3): 433–451.
    CrossRefPubMed
  8. Standardy opieki ambulatoryjnej nad dzieckiem urodzonym przedwcześnie. Zalecenia Polskiego Towarzystwa Neonatologicznego i Polskiego Towarzystwa Pediatrycznego. Media Press 2017.
  9. Kułaga Z, Litwin M, Grajda A, et al. OLAF Study Group. Oscillometric blood pressure percentiles for Polish normal-weight school-aged children and adolescents. J Hypertens. 2012; 30(10): 1942–1954.
    CrossRefPubMed
  10. Symonides B, Jędrusik P, Artyszuk L, et al. Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students. Arch Med Sci. 2010; 6(5): 689–694.
    CrossRefPubMed
  11. Dereziński T, Kułaga Z, Litwin M. Prevalence of arterial hypertension and anthropometrical predictors of elevated blood pressure in 14 years old adolescents. Postępy Nauk Medycznych. 2015; 28(11): 756–759.
    CrossRef
  12. Luyckx VA, Perico N, Somaschini M, et al. writing group of the Low Birth Weight and Nephron Number Working Group. A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group. Lancet. 2017; 390(10092): 424–428.
    CrossRefPubMed
  13. Lurbe E, Cifkova R, Cruickshank JK, et al. Sociedad Europea de Hipertensión, European Society of Hypertension. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009; 27(9): 1719–1742.
    CrossRefPubMed
  14. Rozporządzenie Ministra Zdrowia z dnia 29 sierpnia 2009 r. w sprawie świadczeń gwarantowanych z zakresu podstawowej opieki zdrowotnej Dz. U. 2009.139.1139.
  15. Constantine E, Merritt C, Constantine E, et al. The assessment and management of hypertensive emergencies and urgencies in children. Pediatr Emerg Care. 2005; 21(6): 391–6; quiz 397.
    PubMed
  16. Flynn JT, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol. 2009; 24(6): 1101–1112.
    CrossRefPubMed
  17. Flynn JT, Daniels SR, Hayman LL, et al. American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014; 63(5): 1116–1135.
    CrossRefPubMed
  18. Kit BK, Kuklina E, Carroll MD, et al. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report): 555–576.
    PubMed
  19. Parati G, Stergiou GS, Asmar R, et al. ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008; 26(8): 1505–1526.
    CrossRefPubMed
  20. Stergiou GS, Christodoulakis G, Giovas P, et al. Home blood pressure monitoring in children: how many measurements are needed? Am J Hypertens. 2008; 21(6): 633–638.
    CrossRefPubMed
  21. Wright JT, Williamson JD, Whelton PK, et al. SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373(22): 2103–2116.
    CrossRefPubMed
  22. Atkins ER, Rodgers A, Xie X, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016; 387(10017): 435–443.
    CrossRefPubMed
  23. Aatola H, Magnussen CG, Koivistoinen T, et al. Simplified definitions of elevated pediatric blood pressure and high adult arterial stiffness. Pediatrics. 2013; 132(1): e70–e76.
    CrossRefPubMed
  24. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Subcommittee On Screening And Management Of High Blood Pressure In Children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3).
    CrossRefPubMed
  25. Obrycki Ł, Litwin M. Nowe amerykańskie wytyczne postępowania w nadciśnieniu tętniczym u dzieci i młodzieży – najważniejsze zmiany wraz z komentarzem. Stand Med Ped. 2018; 15: 47–55.
  26. Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol. 2010; 25(12): 2489–2499.
    CrossRefPubMed
  27. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992; 20(5): 1251–1260.
    PubMed
  28. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22(2): 107–133.
    CrossRefPubMed
  29. Litwin M, Niemirska A, Sladowska J, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol. 2006; 21(6): 811–819.
    CrossRefPubMed
  30. Khoury PR, Mitsnefes M, Daniels SR, et al. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009; 22(6): 709–714.
    CrossRefPubMed
  31. Dallaire F, Slorach C, Hui W, et al. Reference values for pulse wave Doppler and tissue Doppler imaging in pediatric echocardiography. Circ Cardiovasc Imaging. 2015; 8(2): e002167.
    CrossRefPubMed
  32. de Simone G, Devereux RB, Daniels SR, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995; 25(5): 1056–1062.
    PubMed
  33. Ong YT, Wong TY, Klein R, et al. Hypertensive retinopathy. N Engl J Med. 2004; 351(22): 2310–2317.
    CrossRefPubMed
  34. Dodson PM, Lip GY, Eames SM, et al. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens. 1996; 10(2): 93–98.
    PubMed
  35. Feig DI, Johnson RJ. The role of uric acid in pediatric hypertension. J Ren Nutr. 2007; 17(1): 79–83.
    CrossRefPubMed
  36. Loeffler LF, Navas-Acien A, Brady TM, et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension. 2012; 59(4): 811–817.
    CrossRefPubMed
  37. Reusz GS, Cseprekal O, Temmar M, et al. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension. 2010; 56(2): 217–224.
    CrossRefPubMed
  38. Van Bortel LM, Laurent S, Boutouyrie P, et al. Artery Society, European Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012; 30(3): 445–448.
    CrossRefPubMed
  39. Fischer DC, Schreiver C, Heimhalt M, et al. Pediatric reference values of carotid-femoral pulse wave velocity determined with an oscillometric device. J Hypertens. 2012; 30(11): 2159–2167.
    CrossRefPubMed
  40. Jourdan C, Wühl E, Litwin M, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens. 2005; 23(9): 1707–1715.
    PubMed
  41. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009; 24(4): 707–719.
    CrossRefPubMed
  42. Doyon A, Kracht D, Bayazit AK, et al. 4C Study Consortium. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension. 2013; 62(3): 550–556.
    CrossRefPubMed
  43. Litwin M, Sladowska-Kozlowska K. Diagnostyka różnicowa nadciśnienia tętniczego u młodzieży. In: Litwin M, Prejbisz A, Januszewicz A. ed. Nadciśnienie tętnicze u młodzieży i młodych dorosłych. Medycyna Praktyczna 2011.
  44. Wühl E, Trivelli A, Picca S, et al. ESCAPE Trial Group. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009; 361(17): 1639–1650.
    CrossRefPubMed
  45. Litwin M. Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol. 2004; 19(2): 178–186.
    CrossRef
  46. Litwin M, Grenda R, Sladowska J, et al. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol. 2006; 21(11): 1716–1722.
    CrossRefPubMed
  47. Hadtstein C, Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol. 2008; 23(3): 363–371.
    CrossRefPubMed
  48. Halbach SM, Martz K, Mattoo T, et al. Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr. 2012; 160(4): 621–625.e1.
    CrossRefPubMed
  49. Kramer AM, van Stralen KJ, Jager KJ, et al. Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int. 2011; 80(10): 1092–1098.
    CrossRefPubMed
  50. Tkaczyk M, Nowicki M, Bałasz-Chmielewska I, et al. Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant. 2006; 21(3): 736–742.
    CrossRefPubMed
  51. Chavers BM, Solid CA, Daniels FX, et al. Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol. 2009; 4(8): 1363–1369.
    CrossRefPubMed
  52. Chaudhuri A, Sutherland SM, Begin B, et al. Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis. Clin J Am Soc Nephrol. 2011; 6(4): 870–876.
    CrossRefPubMed
  53. Inrig JK, Patel UD, Gillespie BS, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis. 2007; 50(1): 108–18, 118.e1.
    CrossRefPubMed
  54. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007; 11(1): 21–31.
    CrossRefPubMed
  55. Paglialonga F, Ardissino G, Galli MA, et al. Bioimpedance analysis and cardiovascular status in pediatric patients on chronic hemodialysis. Hemodial Int. 2012; 16 Suppl 1: S20–S25.
    CrossRefPubMed
  56. Jain SR, Smith L, Brewer ED, et al. Non-invasive intravascular monitoring in the pediatric hemodialysis population. Pediatr Nephrol. 2001; 16(1): 15–18.
    CrossRefPubMed
  57. Dietel T, Filler G, Grenda R, et al. Bioimpedance and inferior vena cava diameter for assessment of dialysis dry weight. Pediatr Nephrol. 2000; 14(10-11): 903–907.
    PubMed
  58. Laakkonen H, Happonen JM, Marttinen E, et al. Normal growth and intravascular volume status with good metabolic control during peritoneal dialysis in infancy. Pediatr Nephrol. 2010; 25(8): 1529–1538.
    CrossRefPubMed
  59. Ortega LM, Materson BJ. Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment. J Am Soc Hypertens. 2011; 5(3): 128–136.
    CrossRefPubMed
  60. Levey AS, Rocco MV, Anderson S, et al. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43(5 Suppl 1): S1–S290..
    CrossRefPubMed
  61. Tentori F, Zhang J, Li Y, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2012; 27(11): 4180–4188.
    CrossRefPubMed
  62. Hoppe A, von Puttkamer C, Linke U, et al. A hospital-based intermittent nocturnal hemodialysis program for children and adolescents. J Pediatr. 2011; 158(1): 95–9, 99.e1.
    CrossRefPubMed
  63. Tan BK, Chan C, Davies SJ. Achieving euvolemia in peritoneal dialysis patients: a surprisingly difficult proposition. Semin Dial. 2010; 23(5): 456–461.
    CrossRefPubMed
  64. Wong H, Mylrea K, Feber J, et al. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int. 2006; 70(3): 585–590.
    CrossRefPubMed
  65. Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014; 129(9): 1048–1078.
    CrossRefPubMed
  66. Green R, Gu X, Kline-Rogers E, et al. Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry. Pediatr Nephrol. 2016; 31(4): 641–650.
    CrossRefPubMed
  67. Slovut DP, Olin JW, Slovut DP, et al. Fibromuscular dysplasia. N Engl J Med. 2004; 350(18): 1862–1871.
    CrossRefPubMed
  68. Anderson WP, Kett MM, Stevenson KM, et al. Renovascular hypertension: structural changes in the renal vasculature. Hypertension. 2000; 36(4): 648–652.
    CrossRefPubMed
  69. Antoniewicz J, Litwin M, Pędich M, et al. Diagnosis and treatment of renovascular hypertension in children and adolescents — single center experience with 87 patients. J Hypertens. 2007; 25(suppl. 2): S332.
  70. Trautmann A, Roebuck DJ, McLaren CA, et al. Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension. Pediatr Nephrol. 2017; 32(3): 495–502.
    CrossRefPubMed
  71. Tullus K, Roebuck DJ, McLaren CA. Imaging in the evaluation of renovascular disease. Pediatr Nephrol. 2010; 25(6): 1049–1056.
    CrossRefPubMed
  72. Shroff R, Roebuck DJ, Gordon I, et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics. 2006; 118(1): 268–275.
    CrossRefPubMed
  73. Kari JA, Roebuck DJ, McLaren CA, et al. Angioplasty for renovascular hypertension in 78 children. Arch Dis Child. 2015; 100(5): 474–478.
    CrossRefPubMed
  74. Aggoun Y, Sidi D, Bonnet D. [Arterial dysfunction after treatment of coarctation of the aorta]. Arch Mal Coeur Vaiss. 2001; 94(8): 785–789.
    PubMed
  75. Bhat MA, Neelakandhan KS, Unnikrishnan M, et al. Fate of hypertension after repair of coarctation of the aorta in adults. Br J Surg. 2001; 88(4): 536–538.
    CrossRefPubMed
  76. Daniels SR. Repair of coarctation of the aorta and hypertension: does age matter. Lancet. 2001; 358(9276): 89–91.
    CrossRefPubMed
  77. O'Sullivan JJ, Derrick G, Darnell R. Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24 hour blood pressure measurement. Heart. 2002; 88(2): 163–166.
    CrossRefPubMed
  78. de Divitiis M, Pilla C, Kattenhorn M, et al. Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta. J Am Coll Cardiol. 2003; 41(12): 2259–2265.
    PubMed
  79. Brzezinska-Rajszys G, Qureshi SA, Ksiazyk J, et al. Middle aortic syndrome treated by stent implantation. Heart. 1999; 81(2): 166–170.
    CrossRefPubMed
  80. Adelman RD, Coppo R, Dillon MJ. The emergency management of severe hypertension. Pediatr Nephrol. 2000; 14(5): 422–427.
    PubMed
  81. Araki N, Umemura M, Miyagi Y, et al. Expression, transcription, and possible antagonistic interaction of the human Nedd4L gene variant: implications for essential hypertension. Hypertension. 2008; 51(3): 773–777.
    CrossRefPubMed
  82. Atanasov AG, Ignatova ID, Nashev LG, et al. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol. 2007; 18(4): 1262–1270.
    CrossRefPubMed
  83. Bilginturan N, Zileli S, Karacadag S, et al. Hereditary brachydactyly associated with hypertension. J Med Genet. 1973; 10(3): 253–259.
    PubMed
  84. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule. N Engl J Med. 1994; 330(3): 178–181.
    CrossRefPubMed
  85. Li A, Tedde R, Krozowski ZS, et al. Molecular basis for hypertension in the. Am J Hum Genet. 1998; 63(2): 370–379.
    CrossRefPubMed
  86. Toka O, Maass PG, Aydin A, et al. Childhood hypertension in autosomal-dominant hypertension with brachydactyly. Hypertension. 2010; 56(5): 988–994.
    CrossRefPubMed
  87. Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol. 2009; 24(10): 1929–1937.
    CrossRefPubMed
  88. Stewart PM. Dexamethasone-suppressible hypertension. Lancet. 2000; 356(9231): 697–699.
    CrossRefPubMed
  89. Zimmet P, Alberti KG, Kaufman F, et al. IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007; 8(5): 299–306.
    CrossRefPubMed
  90. Litwin M, Sladowska J, Syczewska M, et al. Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension. Am J Hypertens. 2007; 20(8): 875–882.
    CrossRefPubMed
  91. Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol. 2010; 25(12): 2489–2499.
    CrossRefPubMed
  92. Jarosz-Chobot P, Polanska J, Szadkowska A, et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia. 2011; 54(3): 508–515.
    CrossRefPubMed
  93. Fendler W, Borowiec M, Baranowska-Jazwiecka A, et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia. 2012; 55(10): 2631–2635.
    CrossRefPubMed
  94. Margeirsdottir HD, Larsen JR, Brunborg C, et al. Norwegian Study Group for Childhood Diabetes. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia. 2008; 51(4): 554–561.
    CrossRefPubMed
  95. Rodriguez BL, Dabelea D, Liese AD, et al. SEARCH Study Group. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr. 2010; 157(2): 245–251.e1.
    CrossRefPubMed
  96. Knerr I, Dost A, Lepler R, et al. Diabetes Data Acquisition System for Prospective Surveillance (DPV) Scientific Initiative Germany and Austria. Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes: a multicenter longitudinal survey in Germany and Austria. Diabetes Care. 2008; 31(4): 726–727.
    CrossRefPubMed
  97. Mayer-Davis EJ, Ma Bo, Lawson A, et al. SEARCH for Diabetes in Youth Study Group. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009; 7(2): 89–95.
    CrossRefPubMed
  98. Donaghue KC, Wadwa RP, Dimeglio LA, et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20: 257–269.
    CrossRefPubMed
  99. Maahs DM, Daniels SR, de Ferranti SD, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014; 130(17): 1532–1558.
    CrossRefPubMed
  100. Afkarian M. Diabetic kidney disease in children and adolescents. Pediatr Nephrol. 2015; 30(1): 65–74; quiz 70.
    CrossRefPubMed
  101. Pietrzak I, Mianowska B, Gadzicka A, et al. Blood pressure in children and adolescents with type 1 diabetes mellitus--the influence of body mass index and fat mass. Pediatr Endocrinol Diabetes Metab. 2009; 15(4): 240–245.
    PubMed
  102. Delaney A, Pellizzari M, Speiser PW, et al. Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes. Diabetes Care. 2009; 32(1): 165–168.
    CrossRefPubMed
  103. Suláková T, Janda J, Cerná J, et al. Arterial HTN in children with T1DM--frequent and not easy to diagnose. Pediatr Diabetes. 2009; 10(7): 441–448.
    CrossRefPubMed
  104. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002; 347(11): 797–805.
    CrossRefPubMed
  105. Lucini D, Zuccotti G, Malacarne M, et al. Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus. Hypertension. 2009; 54(5): 987–994.
    CrossRefPubMed
  106. Basiratnia M, Abadi SF, Amirhakimi GH, et al. Ambulatory blood pressure monitoring in children and adolescents with type-1 diabetes mellitus and its relation to diabetic control and microalbuminuria. Saudi J Kidney Dis Transpl. 2012; 23(2): 311–315.
    PubMed
  107. Basiratnia M, Abadi SF, Amirhakimi GH, et al. Ambulatory blood pressure monitoring in children and adolescents with type-1 diabetes mellitus and its relation to diabetic control and microalbuminuria. Saudi J Kidney Dis Transpl. 2012; 23(2): 311–315.
    PubMed
  108. Tołwińska J, Głowińska-Olszewska B, Bossowski A. Insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus. Mediators Inflamm. 2013; 2013: 791283.
    CrossRefPubMed
  109. Maahs DM, Daniels SR, de Ferranti SD, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014; 130(17): 1532–1558.
    CrossRefPubMed
  110. Harrington J, Peña AS, Gent R, et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr. 2010; 156(2): 237–241.
    CrossRefPubMed
  111. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004; 25(4): 543–567.
    CrossRefPubMed
  112. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006; 114(24): 2710–2738.
    CrossRefPubMed
  113. Afkarian M. Diabetic kidney disease in children and adolescents. Pediatr Nephrol. 2015; 30(1): 65–74; quiz 70.
    CrossRefPubMed
  114. Salardi S, Balsamo C, Zucchini S, et al. High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol. Diabetes Care. 2011; 34(2): 424–429.
    CrossRefPubMed
  115. Rodriguez BL, Dabelea D, Liese AD, et al. SEARCH Study Group. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr. 2010; 157(2): 245–251.e1.
    CrossRefPubMed
  116. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013; 36(6): 1735–1741.
    CrossRefPubMed
  117. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013; 36(6): 1758–1764.
    CrossRefPubMed
  118. Springer SC, Silverstein J, Copeland K, et al. American Academy of Pediatrics. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics. 2013; 131(2): e648–e664.
    CrossRefPubMed
  119. 2015 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabetol. 2015; 4(Suppl. A): A41–A47.
  120. Maahs DM, Daniels SR, de Ferranti SD, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014; 130(17): 1532–1558.
    CrossRefPubMed
  121. American Diabetes Association. Standards of medical care in diabetes —2014. Diabetes Care. 2014; 37(Suppl 1): S14–S80.
    CrossRefPubMed
  122. Chatterjee M, Speiser PW, Pellizzarri M, et al. Poor glycemic control is associated with abnormal changes in 24-hour ambulatory blood pressure in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2009; 22(11): 1061–1067.
    PubMed
  123. Bullo M, Tschumi S, Bucher BS, et al. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012; 60(2): 444–450.
    CrossRefPubMed
  124. Constantine E, Merritt C, Constantine E, et al. The assessment and management of hypertensive emergencies and urgencies in children. Pediatr Emerg Care. 2005; 21(6): 391–6; quiz 397.
    PubMed
  125. Task Force on Blood Pressure Control in Children. Report of the Second Task Force on Blood Pressure Control in Children — 1987. Pediatrics. 1987; 79(1): 1–25.
  126. Skalina ME, Kliegman RM, Fanaroff AA. Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol. 1986; 3(3): 235–239.
    CrossRefPubMed
  127. Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol. 1987; 1(1): 30–34.
    PubMed
  128. Buchi KF, Siegler RL. Hypertension in the first month of life. J Hypertens. 1986; 4(5): 525–528.
    PubMed
  129. Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol. 2012; 27(1): 17–32.
    CrossRefPubMed
  130. Low JA, Panagiotopoulos C, Smith JT, et al. Validity of newborn oscillometric blood pressure. Clin Invest Med. 1995; 18(3): 163–167.
    PubMed
  131. Langbaum M, Eyal FG. A practical and reliable method of measuring blood pressure in the neonate by pulse oximetry. J Pediatr. 1994; 125(4): 591–595.
    PubMed
  132. Nwankwo MU, Lorenz JM, Gardiner JC. A standard protocol for blood pressure measurement in the newborn. Pediatrics. 1997; 99(6): E10.
    PubMed
  133. Park MK, Menard SM. Normative oscillometric blood pressure values in the first 5 years in an office setting. Am J Dis Child. 1989; 143(7): 860–864.
    PubMed
  134. Park MK, Menard SW, Yuan C. Comparison of auscultatory and oscillometric blood pressures. Arch Pediatr Adolesc Med. 2001; 155(1): 50–53.
    PubMed
  135. O’Brien E, Mee F, Atkins N, et al. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996; 1(1): 55–61.
    PubMed
  136. Peterson AL, Frommelt PC, Mussatto K. Presentation and echocardiographic markers of neonatal hypertensive cardiomyopathy. Pediatrics. 2006; 118(3): e782–e785.
    CrossRefPubMed
  137. Watkinson M. Hypertension in the newborn baby. Arch Dis Child Fetal Neonatal Ed. 2002; 86(2): F78–F81.
    PubMed
  138. Feld LG, Waz WR. Pharmacologic therapy of hypertension. In: Feld LG. ed. Hypertension in Children. Butterworth-Heinemann, Boston 1997: 133–178.
  139. Luyckx VA, Perico N, Somaschini M, et al. writing group of the Low Birth Weight and Nephron Number Working Group. A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group. Lancet. 2017; 390(10092): 424–428.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl